Form 4: Cingulate Inc. Director Peter J. Werth Acquires Stock Options

Director Peter J. Werth acquired stock options in Cingulate Inc. following stockholder approval of an amendment to the equity incentive plan.

Summary

• Peter J. Werth, a director and 10% owner of Cingulate Inc., reported the acquisition of stock options.
• On June 11, 2024, Werth acquired 6,926 stock options with an exercise price of $1.18, vesting on the one-year anniversary of the grant date, and expiring on March 4, 2034.
• These options were granted in lieu of $13,852 in cash retainer fees.
• On June 12, 2024, Werth acquired 10,000 stock options with an exercise price of $0.7, vesting on the one-year anniversary of the grant date, and expiring on June 12, 2034.
• The stock option grant was approved by Cingulate Inc.'s board of directors on March 4, 2024, subject to stockholder approval of Amendment No.1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan, which was obtained on June 11, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a director suggests confidence, but it's a routine transaction.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Stock option grants are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the pharmaceutical and biotechnology industries.
• The vesting schedules and exercise prices are typical for such grants, often tied to continued service and company performance.
• Comparable companies often use similar equity incentive plans to attract and retain key personnel.

Stakeholder Impact

• The stock option grants could potentially incentivize the director to work towards increasing shareholder value.

Key Dates

Keywords

stock options, Cingulate Inc., director, Peter J. Werth, equity incentive plan, beneficial ownership, Form 4